This site contains information about prescription peptide therapy protocols intended for adults. You must be 18 years of age or older to enter.
By entering, you confirm you are at least 18 years old and agree to our Terms of Service. All protocols require a valid physician prescription.
A naturally occurring human tripeptide that binds copper ions and drives collagen synthesis, wound healing, and antioxidant defense. Studied for its ability to influence gene expression toward a more youthful biological state.
GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring tripeptide first isolated from human plasma in the 1970s by Dr. Loren Pickart. It consists of three amino acids — glycine, histidine, and lysine — bound to a copper ion. This copper-peptide complex is found throughout the body in plasma, urine, and saliva, with levels declining significantly with age.
At the cellular level, GHK-Cu activates dermal fibroblasts — the cells responsible for producing collagen, elastin, and the extracellular matrix that gives skin its structure. It also promotes blood vessel formation, supports nerve growth, and activates the body's antioxidant enzyme systems to reduce oxidative damage.
Perhaps its most remarkable studied property is its effect on gene expression. Research led by Dr. Pickart found that GHK-Cu influences the activity of approximately 31% of human genes, including genes associated with inflammation, tissue remodeling, and biological aging — a reset effect that has made it one of the most studied anti-aging peptides in the field.
GHK-Cu influences up to 31% of human genes, downregulating inflammatory and aging-associated pathways while upregulating regenerative ones — a documented biological reset mechanism.
Directly activates dermal fibroblasts to produce collagen types I, III, and IV and elastin — the structural proteins responsible for skin firmness, texture, and elasticity.
Enhances the full wound healing cascade: attracts repair cells, increases blood vessel formation, and accelerates collagen deposition at injury sites.
Activates superoxide dismutase and other antioxidant enzymes, reducing free radical damage that accelerates cellular aging and tissue breakdown.
Modulates inflammatory signaling pathways, reducing chronic low-grade inflammation that contributes to skin aging, tissue damage, and systemic aging processes.
Promotes new blood vessel formation, improving nutrient and oxygen delivery to skin and healing tissue — a key driver of the regenerative environment GHK-Cu creates.
GHK-Cu is used both topically and via subcutaneous injection, depending on the application. Topical use targets skin surface benefits (texture, tone, wrinkle reduction). Subcutaneous injection is used for systemic wound healing, tissue repair, and deeper anti-aging applications.
Reconstitution follows standard peptide protocol: bacteriostatic water added gently along the vial wall to achieve a working concentration of 2–5 mg/mL. Avoid vigorous shaking — swirl gently until dissolved.
| Application | Dose | Frequency | Duration |
|---|---|---|---|
| Systemic (SC injection) | 1.0 – 2.0 mg | Daily or every other day | 4 – 12 weeks |
| Topical | Apply to clean, dry skin | Once or twice daily | Ongoing |
| Route (injection) | Subcutaneous — abdomen, upper thigh, or near target area | ||
| Storage | Lyophilized: refrigerate. Reconstituted: use within 30 days, keep refrigerated. | ||
GHK-Cu has one of the longest research histories of any peptide — over five decades of published science dating back to Dr. Loren Pickart's initial discovery in 1973. The evidence base spans in vitro, animal, and human studies across dermatology, wound care, and molecular biology.
Dr. Pickart's database analysis found GHK-Cu affects the expression of approximately 31.2% of human genes, including 84 genes that reset from an aged gene expression pattern to a more youthful state.
Multiple in vitro and human studies confirm GHK-Cu increases collagen synthesis in dermal fibroblasts, with one study showing a 70% increase in collagen production versus untreated controls.
Clinical studies in wound care (including post-surgical applications) demonstrate faster wound closure, reduced scarring, and increased dermal thickness versus placebo in GHK-Cu treated subjects.
Double-blind studies show GHK-Cu topical application reduces fine lines, improves skin laxity, and increases skin thickness — effects attributable to its collagen-stimulating and antioxidant properties.
Yes — GHK-Cu (glycyl-L-histidyl-L-lysine copper) is the same compound marketed as "copper peptide" in premium skincare lines. The research peptide vial form is identical in molecule, with higher purity standards and independent COA verification compared to most cosmetic formulations.
For skin surface benefits (fine lines, texture, tone), topical application delivers the peptide where you need it without systemic exposure. For wound healing, tissue repair, or anti-aging at a systemic level, subcutaneous injection provides broader distribution. Many protocols combine both: injections for systemic effect, topical for targeted skin application.
Topical effects on skin texture and fine lines are typically reported at 6–12 weeks of consistent use. Deeper structural changes (increased skin thickness, improved elasticity from collagen synthesis) take longer — most researchers observe meaningful changes at 3–6 months.
Dr. Loren Pickart analyzed GHK-Cu's effect on the human genome using gene expression databases and found it modulates approximately 31% of genes — including those governing inflammation, copper transport, collagen synthesis, and biological aging pathways. This is a bioinformatics analysis, not a direct in vivo measurement, but the scale of influence is well-documented and cited widely in longevity research.
GHK-Cu has an excellent safety profile supported by decades of research — it is naturally present in the human body and is one of the least controversial research peptides available. Copper toxicity is a theoretical concern at extremely high doses, but the amounts used in standard research protocols are well within physiological ranges.
GHK-Cu is sold for research purposes only. It has not been approved by the FDA for human use as a drug, and the information on this page is educational in nature and does not constitute medical advice. Consult a qualified healthcare professional before considering any peptide protocol. Individual results vary.
Third-party tested GHK-Cu with Finnrick Analytics verification. Full COA on every batch. Ships within 24 hours.
Get Started TodayMedical Disclaimer: The information on this page is for educational purposes only and does not constitute medical advice. All protocols require evaluation and prescription by a licensed physician. You should consult a qualified healthcare provider before starting any new medical protocol. Individual results vary. Cinch Bio is not a pharmacy and does not dispense medications — all prescriptions are issued by independent licensed physicians and filled by licensed 503A compounding pharmacies.